Meeting the Unmet Need in the Management of MDR Gram-Positive Infections with Oral Bactericidal Agent Levonadifloxacin
Author:
Affiliation:
1. Medanta the Medicity, Gurgaon, India
2. Yashoda Hospital, Secunderabad, India
3. Fortis Hospital, Kolkata, India
4. Manipal Hospital, Bengaluru, India
5. Apollo Hospitals, Bhubaneshwar, India
6. Wockhardt Ltd, Mumbai, India
Abstract
Publisher
Hindawi Limited
Subject
Critical Care and Intensive Care Medicine
Link
http://downloads.hindawi.com/journals/ccrp/2022/2668199.pdf
Reference76 articles.
1. Emerging Treatment Options for Infections by Multidrug-Resistant Gram-Positive Microorganisms
2. The Continuing Threat of Methicillin-Resistant Staphylococcus aureus
3. Prevalence and genotype distribution of methicillin-resistant Staphylococcus aureus (MRSA) in India
4. Emerging multidrug-resistant Bengal Bay clone ST772-MRSA-V in Norway: molecular epidemiology 2004–2014
5. In vitro activity of a novel antibacterial agent, levonadifloxacin, against clinical isolates collected in a prospective, multicentre surveillance study in India during 2016–18
Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Treatment challenges in the management of difficult-to-treat gram-positive infections: A consensus view apropos therapeutic role of novel anti-MRSA antibiotics, levonadifloxacin (IV) and alalevonadifloxacin (oral);Indian Journal of Medical Microbiology;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3